Drawing for BRCASCOOP

USPTO serial 77807601

BRCASCOOP

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SOBRAL, CHRISTINA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BRCASCOOP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
041Providing on-line journals, namely, weblogs, NAMELY, blogs featuring health, genetic, and/or medical information related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing continuing medical education seminars; Providing non-downloadable electronic journals featuring health, genetic, and/or medical information related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing electronic ONLINE journals featuring health, genetic, and/or medical information related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer by email distribution; Providing newsletters in the field of genetic and health information for personalized health and/or wellness information purposes related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer via email; Providing up-to-date news relating to science and technology; Publishing services, namely, publication of newspapers, periodicals, catalogues, magazines, books, abstracts, newsletter and bulletins related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Provision of electronic publishing services, namely, on-line publication of text and graphic works of others in the field of scientific and technological research from a computer database or via the internet related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Educational services, namely, providing courses of instruction relating to science, technology, health, genetics, and medicine related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Dissemination of educational materials OF OTHERS in the fields of health, science and technology, genetics, medicine, entertainment, and CURRENT EVENT NEWS gossip; Entertainment services, namely, providing a website or websites featuring entertainment materials in the nature of publications, namely, books, book excerpts, magazines, newspapers, periodicals, journals, newsletters, and manuals in the fields of health, science and technology, genetics, medicine, entertainment, and CURRENT EVENT NEWS IN THE NATURE OF gossip; Providing on-line publications in the nature of guides listing and providing information on books, magazines, newspapers, periodicals, journals, newsletters, manuals, audio and video recordings, podcasts, blogs and computer software related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; online journals, namely, blogs featuring information on books, magazines, newspapers, periodicals, journals, newsletters, manuals, audio and video recordings, computer software, education, entertainment, health, science and technology, genetics, medicine, CURRENT EVENT NEWS IN THE NATURE OF gossip, and editorials related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing newsletters in the field of health, science and technology, genetics, and/or medicine related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer via email; Providing links to the websites of others concerning information related to CURRENT EVENT NEWS IN THE NATURE OF gossip, entertainment, and ONLINE PUBLICATIONS, NAMELY, editorials related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancerACTIVE—
044Providing health information related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing healthcare information via the internet related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing a website featuring EDUCATIONAL information related to health, genetics, and/or medicine related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing an internet-based database of EDUCATIONAL information where individuals can inquire about medical, health and genetic issues from other individuals and can relay information about their experiences for support and community related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing links to the websites of others concerning EDUCATIONAL information related to health, genetics, and medicine related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing EDUCATIONAL information in the fields of health, wellness, genetics, medicine, and genetic or genomic testing related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing EDUCATIONAL INFORMATION IN THE FIELDS OF health, genetics, medical information via video, video-on-demand, audio, and/or audio-on-demand related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing databases FEATURING EDUCATIONAL INFORMATION in the fields of health, wellness, genetics, and medicine related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancer; Providing EDUCATIONAL INFORMATION, consultancy and advisory services IN THE FIELDS OF health, GENETICS, genetic TESTING and/or medical information related to breast and ovarian cancer, including hereditary breast and ovarian cancer and familial breast and ovarian cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 11, 2011MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 10, 2011ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 9, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 8, 2011EX1GSOU EXTENSION 1 GRANTED—
Jun 8, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 6, 2011TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jun 6, 2011PETGPETITION TO REVIVE-GRANTED—
Jun 6, 2011PROATEAS PETITION TO REVIVE RECEIVED—
Apr 11, 2011MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 11, 2011ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 7, 2011EXT1SOU EXTENSION 1 FILED—
Sep 7, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 13, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 13, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2010ALIEASSIGNED TO LIE—
May 26, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 21, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 20, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2009DOCKASSIGNED TO EXAMINER—
Aug 22, 2009MPMKNOTICE OF PSEUDO MARK MAILED—
Aug 21, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 21, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance